Key facts
- This page summarizes Edward R. Conner's Form 4 filing for Third Harmonic Bio, Inc. (THRD).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Nov 2024, 17:08.
Edward R. Conner - 08 Nov 2024 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- THRD
- Reported as of
- 08 Nov 2024
- Net transaction value
- -$22,864
- SEC form
- 4
- Accepted by SEC
- 12 Nov 2024, 17:08:24 UTC
- Prior SEC filing
- 30 Oct 2024
- Next SEC filing
- 17 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher Murphy, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Edward R. Conner filed Form 4 for Third Harmonic Bio, Inc. (THRD) on 12 Nov 2024.
Change
- Previous filing in this sequence was filed on 30 Oct 2024.
- Current net transaction value: -$22,864.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
THRD
transaction
Common Stock
Options Exercise
- Transaction value
- $8,891
- Shares
- +2,117
- Change %
- Price
- $4.20
- Shares after
- 2,117
- Date
- 08 Nov 2024
- Ownership
- Direct
THRD
transaction
Common Stock
Sale
- Transaction value
- $31,755
- Shares
- -2,117
- Change %
- -100%
- Price
- $15.00
- Shares after
- 0
- Date
- 08 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
THRD
transaction
Derivative
Employee Option Grant (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,117
- Change %
- -0.57%
- Price
- $0.000000
- Shares after
- 368,918
- Date
- 08 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,117
- Exercise price
- $4.20
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 2 footnotes
Footnote F1
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated March 27, 2024.
Footnote F2
25% of the total shares vest on June 6, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.